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All assays were performed with passages 3-7 hCPC at 80-90% confluence. Stimulation with IFNγ (500IU/ml) mimicked post-MI inflammatory conditions. Table S3 ) using Ficoll gradient centrifugation. CD14 + CD16 -monocytes were isolated by negative selection using MACS magnetic beads (Miltenyi Biotec, Germany) following manufacturer's instructions to ≥ 95% purity.
Cardiomyocytes, Endothelial cells, and Human monocytes

Isolation of Extracellular Vesicles (EV) secreted by hCPC
EV secreted by hCPC were isolated according to the latest guidelines [21, 22] and using sequential differential ultracentrifugation as isolation method given its adequacy and common application to isolate EVs from supernatants of stem/progenitor cells cultures for cardiac repair/regeneration studies [8] . Briefly, at 80-90% confluence, hCPC or IFNγ-hCPC were washed (2X) with FBS-free medium then re-cultured in FBS-free appropriate medium for another 48 h. Culture supernatants were filtered through a 0,22μm filter then centrifuged at 10,000g for 30 min at 4°C to remove any residual cells, contaminating apoptotic bodies, majority of microvesicles and cell debris. The clarified supernatants were then ultra-centrifuged at 30.000k (110,000g) using an SW 32TI 4 rotor (Beckman coulter ultracentrifuge) for 2h at 4°C to pellet EVs. These pellets were then washed by re-suspension in PBS, ultra-centrifuged at 110,000g for another 2h at 4°C. The resulting pellet was then re-suspended in PBS and stored as aliquots at −80°C. EVs were then quantified and characterized by Nanoparticle Tracking Analysis (NTA) (3.0, Malvern) using the NanoSight LM-14 (Malvern Instruments, Malvern, UK) and electron microscopy. For NTA, one-minute videos were recorded in five replicates per sample. The temperature was automatically monitored and ranged from 20°C to 21° C. Videos were analyzed when a sufficient number of valid trajectories was measured.
The presented results correspond to the mean of the five videos taken for a given biological sample (Supplementary Fig. 2A ). EVs were also analyzed by Western blotting for the enrichment of specific small-EVs/exosome markers the tetraspaninsCD63 and CD81, MHC class I and actin in total proteins extracted from EVs. Briefly, cells or EVs pellets were lysed in RIPA buffer (OZYME, Montigny-leBretonneux, France), incubated 30 min at 4°C and then centrifuged (14,000 g, 10 min, 4°C).
Supernatants were recovered and protein content was quantified by Bradford assay (Bio-Rad, Marnes-la-Coquette, France). Proteins (25 µg) were separated by 10% SDS-PAGE, transferred onto PVDF membrane, and probed with anti-CD81 (Cell signaling by Ozyme), anti-CD63 (abcam) or anti-HLA I (Biolegend). Immunoblots were treated with an HRP-conjugated secondary antibody (Santa Cruz Biotechnologies, Heidelberg, Germany) followed by enhanced chemiluminescence detection and phosphorimaging (OZYME). Re-probing with an anti-b-actin antibody (Sigma-Aldrich, Saint-Quentin Fallavier, France) ensured equal loading.
Characterization of EV by Flow Cytometry
Characterization of EV by flow cytometry was conducted as described in [23] . Briefly, EV (25μg) were mixed with 4 μm Aldehyde/Sulfate Latex Beads (Fisher Scientific, Illkirch, France) at room temperature (RT) then the mixture was suspended in PBS and left at RT for another 2h. The coupling reaction was terminated by 100mM glycine and the mixture was centrifuged at 1500g. The beads were then stained with conjugated antibodies for relevant exosomal markers (CD63, CD81, and HLA-I) then analyzed by CANTO II flow Cytometer.
EV cellular internalization
EV were stained with Carboxyfluorescein N-succinimidyl ester (CFSE) (0.5ng/ml) then washed twice with PBS by ultracentrifugation at 110,000g for 2h at 4°C. Uptake of CFSE-labeled EV by assessed. Cells (10 5 ) were plated on chamber-slides and allowed to adhere for 24h at 37°C under 3%
O2 for hCPCs, and under 5% CO2 for monocytes, HMEC, HUVEC, and AC16. After complete adhesion, cells were washed with PBS and incubated in their respective medium in the presence of 50µg CFSE-labeled EV for 8h. Cells were then fixed with 4% paraformaldehyde (PFA) then washed with PBS and blocked with 5% normal goat serum 0.1%PBS-Tween for 1h. Cells were then stained with anti-HLA I overnight at 4°C, followed by a further incubation at RT for 1h with DyLight 594 secondary antibodies. Slides were mounted using vectashield supplemented with Dapi to identify cell nuclei. Pictures were captured using x200 and x400 magnification using ZEISS ApoTome.2 microscope. For flow cytometry monitoring, EV produced by hCPC were labeled by 50µg CFSE and cultured with cells (10 5 ) in 24 wells plate for 15min, 1h, 4h, and 8h. Cells were then harvested and acquired using CANTO II / ZE5 flow cytometers. CFSE positive cells were determined by Diva/Everest software.
EV-induced signaling
To determine activation of MAPK/Erk pathway in hCPC, cells ( 10 6 ) were seeded in 6-well plates in their complete medium for overnight then starved for 24h after which were treated with either 50µg/ml EV or SN at 37°C as in the presence or absence of 10µM of Mek1/2 specific inhibitor U0126.
Cells were then lysed in RIPA buffer supplemented with 10% Protease inhibitor and 5% Phosphatase inhibitor (Ozyme), proteins were separated on loaded to 10% SDS-PAGE, then transferred to PVDF membrane. Membranes were probed with anti-pErk1/2 (Cell signaling, Leiden, The Netherlands)
followed by an HRP-conjugated antibody (Bio-Rad) then revealed with ECL (Cell Signalling).
Membranes were also probed with anti-Erk1/2 and anti-β-actin antibodies (Cell signaling) for equal loading. The density of each band was determined using Image Quant software.
Human phospho-MAPK Array Kit (ARY003; R&D Systems) was used to analyze the influence of hCPC secreted EV on the activation state of a total of 26 MAPKs and other serine/threonine 6 kinases in endothelial cells. The assay was used according to the manufacturer's instructions, pictures were took using ChemiDoc (Bio-Rad) then analyzed using Cytokines Array Analyzer for ImageJ.
Migration assay
The migratory capacity of hCPC, AC16 cardiomyocytes, HMEC and HUVEC was assessed through wound healing assays. Cells were seeded in 6-well or 96-well (AC16) plates and maintained in their respective medium overnight for adhesion then treated with Mitomycin-C (20μg/ml) for 30min at 37°C. At the end of the treatment, cells were washed with PBS, scratched (wounded), and washed again then maintained in their medium supplemented with 50μg EV, or EV-free supernatant (SN).
Pictures were captured (x40 magnification) using Leica dmi8 microscope every 24h (day0, day1, day2, and day3) or were captured at x10 magnification using Incucyte® every hour. Proliferation was then assessed using Roche BrdU colorimetric ELISA according to manufacturer's 7 instructions. The absorbance was measured at 370 nm with a reference wavelength at 492 nm using 680 Bio Rad plate reader.
For AC16 and HMEC, cells were seeded in 48-well plates at 3x10 4 cell/well, and maintained in their medium overnight for adhesion then starved for 12 hours. After that, cells were treated with either 50µg/ml EV or SN in the presence or absence of 10µM U0126. Proliferation was evaluated by cell counting and by Ki67 (BD pharmingen #556027) staining and flow cytometry using CANTO II flow cytometer and Diva software. For cell growth, cells were seed in 96-well plates at 10 4 cell/well and maintained in their respective medium overnight for adhesion. Cells were then starved for 12 hours and treated with either 50µg/ml EV or SN in the presence or absence of 10µM U0126 and incubated in Incucyte® and their growth was assessed every hour. The percentage of cell growth was determined by Incucyte software after features control.
Tube formation assay
Endothelial cells (10 5 ) were seeded on Matrigel-coated 24-well plates in serum-free DMEM.
Cells were either left unstimulated or stimulated with 50μg of EV or SN. Tube formation images were captured using Leica dmi8 microscope (X40 magnification) and quantified by Angiogenesis analyzer for ImageJ.
Monocytes cultures, immune phenotype, and secretome
Freshly isolated CD14 + CD16 -monocytes were seeded in 48-well plates at 2.5x10 5 cells/well in RPMI 10%-FBS medium and cultured within allogeneic settings for 24h and for 5 days alone or in the presence of 50μg EV. Pictures were captured at the being and at the end of 24h and 5 days cultures.
Cells were then acquired using CANTO-II Flow Cytometer (BD Bioscience) and % of viable and Human Cytokines array kit (R&D systems, ARY005B) were used to determine the relative levels of selected human chemokines/cytokines following manufacturer's instructions.
Statistical Analysis:
Statistical analysis was performed using GraphPad Prism 7 (GraphPad Software Inc.). Data on the graphs represent the mean ± SEM from at least 3 independent experiments. Comparisons were performed using Mann-Whitney test for non-paired groups, paired Student's t-test for paired groups and Two-Way Analysis of Variance (ANOVA)-Sidak's multiple comparisons test for multiple comparisons. A p-value of less than 0.05 was considered statistically significant. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Data analysis using R studio interface. Phospho-Array mean pixel intensity data were exported into an Excel file and analyzed using an in-house R scripts. A heatmap was then generated.
Supplementary Tables   Table S1: Percentage of isolated hCPC among 4 different donors P0: seeding after isolation; P1: first passage in growing medium Table S2 : HLA haplotypes of hCPC hCPC from six donors were genotyped for HLA class I (HLA-A, -B, -C) and class II (HLA-DRB1) to monitor allogenicity in experiments *P < 0.05; **P < 0.01; ***P < 0.001; ****p < 0.0001 compared to medium or SN. (lower panel). *P < 0.05; **P < 0.01; ***P < 0.001. 
